scispace - formally typeset
D

Daniele Rovai

Researcher at National Research Council

Publications -  115
Citations -  2203

Daniele Rovai is an academic researcher from National Research Council. The author has contributed to research in topics: Coronary artery disease & Myocardial infarction. The author has an hindex of 23, co-authored 115 publications receiving 2030 citations. Previous affiliations of Daniele Rovai include Imperial College London & University of Pisa.

Papers
More filters
Journal ArticleDOI

Detection of significant coronary artery disease by noninvasive anatomical and functional imaging.

TL;DR: In a multicenter European population of patients with stable chest pain and low prevalence of CAD, coronary computed tomographic angiography is more accurate than noninvasive functional testing for detecting significant CAD defined invasively.
Journal ArticleDOI

Myocardial Contrast Echocardiography Versus Dobutamine Echocardiography for Predicting Functional Recovery After Acute Myocardial Infarction Treated With Primary Coronary Angioplasty

TL;DR: Contractile reserve elicited by low dose dobutamine is a more accurate predictor of regional functional recovery after reperfused acute myocardial infarction than microvascular integrity.
Journal ArticleDOI

Multicentre multi-device hybrid imaging study of coronary artery disease: results from the EValuation of INtegrated Cardiac Imaging for the Detection and Characterization of Ischaemic Heart Disease (EVINCI) hybrid imaging population.

TL;DR: In patients at intermediate risk of CAD, hybrid imaging allows non-invasive co-localization of myocardial perfusion defects and subtending coronary arteries, impacting clinical decision-making in almost one every five subjects.
Journal ArticleDOI

Prognostic value of pulmonary venous flow Doppler signal in left ventricular dysfunction: contribution of the difference in duration of pulmonary venous and mitral flow at atrial contraction

TL;DR: Assessment of ARd-Ad exhibited an independent value in the prognostic evaluation of patients with LV systolic dysfunction and contributed to identify patients at low, intermediate and high risk of cardiac events.
Journal ArticleDOI

Effects of abciximab on microvascular integrity and left ventricular functional recovery in patients with acute infarction treated by primary coronary angioplasty.

TL;DR: Abciximab improves microvascular perfusion and LV functional recovery in primary PTCA, as demonstrated by greater reduction in wall motion score index and a better recovery of LV function.